2023 |
09/21 | 1,906 | 1,910 | 1,857 | 1,857 | -2.77% | 57,300 | 229億1234万 | +0.43% |
09/20 | 1,890 | 1,931 | 1,890 | 1,910 | +0.21% | 93,900 | 235億6627万 | +3.52% |
09/19 | 1,907 | 1,917 | 1,891 | 1,906 | -0.05% | 68,100 | 235億1692万 | +3.53% |
09/15 | 1,913 | 1,919 | 1,896 | 1,907 | -0.42% | 47,900 | 235億2926万 | +3.81% |
09/14 | 1,925 | 1,925 | 1,901 | 1,915 | -0.26% | 31,900 | 236億2796万 | +4.47% |
09/13 | 12:00 (開示事項の経過)当社子会社による独Evotec社との臨床用iPS細胞作製技術のライセンス契約に関するお知らせ |
09/13 | 1,894 | 1,926 | 1,894 | 1,920 | +0.63% | 56,400 | 236億8966万 | +5.09% |
09/12 | 1,897 | 1,917 | 1,891 | 1,908 | +1.27% | 55,300 | 235億4160万 | +4.72% |
09/11 | 1,889 | 1,893 | 1,867 | 1,884 | +0.27% | 35,700 | 232億4547万 | +3.63% |
09/08 | 1,875 | 1,888 | 1,870 | 1,879 | +0.75% | 52,900 | 231億8378万 | +3.53% |
09/07 | 1,866 | 1,886 | 1,857 | 1,865 | -0.32% | 44,000 | 230億1105万 | +2.81% |
09/06 | 1,853 | 1,876 | 1,853 | 1,871 | +1.03% | 47,000 | 230億8508万 | +3.14% |
09/05 | 1,839 | 1,854 | 1,829 | 1,852 | +0.98% | 49,600 | 228億5065万 | +2.04% |
09/04 | 1,840 | 1,846 | 1,827 | 1,834 | -0.11% | 24,700 | 226億2856万 | +0.94% |
09/01 | 1,814 | 1,837 | 1,814 | 1,836 | +0.82% | 31,600 | 226億5323万 | +0.82% |
08/31 | 1,834 | 1,846 | 1,811 | 1,821 | -0.6% | 59,100 | 224億6816万 | -0.22% |
08/30 | 1,850 | 1,854 | 1,830 | 1,832 | -0.65% | 40,200 | 226億388万 | +0.11% |
08/29 | 1,845 | 1,863 | 1,837 | 1,844 | +1.04% | 63,500 | 227億5194万 | +0.55% |
08/28 | 1,847 | 1,849 | 1,818 | 1,825 | -0.16% | 45,300 | 225億1751万 | -0.71% |
08/25 | 1,805 | 1,846 | 1,795 | 1,828 | +0.99% | 66,200 | 225億5453万 | -0.76% |
08/24 | 1,825 | 1,832 | 1,810 | 1,810 | -0.82% | 32,900 | 223億3244万 | -1.95% |
08/23 | 1,825 | 1,836 | 1,812 | 1,825 | 0% | 36,800 | 225億1751万 | -1.4% |
08/22 | 12:00 (開示事項の経過)当社子会社による京都大学iPS細胞研究財団(iPS財団)とのセンダイiPSの使用条件に関する覚書締結のお知らせ |
08/22 | 1,822 | 1,832 | 1,806 | 1,825 | +0.66% | 51,000 | 225億1751万 | -1.62% |
08/21 | 1,739 | 1,823 | 1,739 | 1,813 | +4.38% | 140,600 | 223億6945万 | -2.42% |
08/18 | 1,702 | 1,744 | 1,693 | 1,737 | +1.16% | 95,800 | 214億3174万 | -6.71% |
08/17 | 1,755 | 1,755 | 1,713 | 1,717 | -2.44% | 164,600 | 211億8497万 | -8.13% |
08/16 | 1,798 | 1,799 | 1,758 | 1,760 | -2.44% | 100,100 | 217億1552万 | -6.23% |
08/15 | 1,817 | 1,828 | 1,800 | 1,804 | -0.11% | 87,800 | 222億5841万 | -4.25% |
08/14 | 1,812 | 1,825 | 1,802 | 1,806 | +0.17% | 50,900 | 222億8308万 | -4.44% |
08/10 | 1,768 | 1,812 | 1,763 | 1,803 | +1.69% | 79,100 | 222億4607万 | -4.85% |
08/09 | 1,782 | 1,812 | 1,773 | 1,773 | -1.12% | 109,200 | 218億7592万 | -6.78% |
08/08 | 1,813 | 1,856 | 1,793 | 1,793 | -1.05% | 204,700 | 221億2268万 | -6.17% |
08/07 | 15:30 株式会社ワールドスキャンプロジェクトとのMedical web3時代のウェルビーイング実現に向けた戦略的パートナーシップ契約締結のお知らせ |
08/07 | 1,726 | 1,815 | 1,726 | 1,812 | -0.44% | 236,200 | 223億5711万 | -5.53% |
08/04 | 15:30 2024年3月期第1四半期決算短信〔日本基準〕(連結) |
08/04 | 1,815 | 1,828 | 1,792 | 1,820 | -0.66% | 124,900 | 224億5582万 | -5.41% |
08/03 | 1,860 | 1,862 | 1,832 | 1,832 | -1.82% | 74,100 | 226億388万 | -5.08% |
08/02 | 1,900 | 1,905 | 1,858 | 1,866 | -2.15% | 113,700 | 230億2338万 | -3.52% |
08/01 | 1,900 | 1,921 | 1,891 | 1,907 | -0.05% | 82,200 | 235億2926万 | -1.55% |
07/31 | 1,939 | 1,943 | 1,907 | 1,908 | -0.68% | 70,400 | 235億4160万 | -1.65% |
07/28 | 1,920 | 1,930 | 1,898 | 1,921 | -1.18% | 68,400 | 237億199万 | -1.08% |
07/27 | 1,944 | 1,953 | 1,903 | 1,944 | +0.15% | 75,100 | 239億8578万 | 0% |
07/26 | 1,925 | 1,945 | 1,923 | 1,941 | +0.31% | 19,100 | 239億4876万 | -0.21% |
07/25 | 1,949 | 1,949 | 1,930 | 1,935 | -0.31% | 28,500 | 238億7473万 | -0.57% |
07/24 | 1,935 | 1,953 | 1,930 | 1,941 | +0.73% | 58,800 | 239億4876万 | -0.31% |
07/21 | 1,919 | 1,936 | 1,917 | 1,927 | +0.1% | 21,400 | 237億7602万 | -1.03% |
07/20 | 1,926 | 1,940 | 1,920 | 1,925 | -0.52% | 21,000 | 237億5135万 | -1.03% |
07/19 | 1,937 | 1,937 | 1,924 | 1,935 | +0.52% | 23,800 | 238億7473万 | -0.51% |
07/18 | 1,909 | 1,925 | 1,905 | 1,925 | +1% | 31,000 | 237億5135万 | -0.98% |
07/14 | 1,929 | 1,930 | 1,897 | 1,906 | -0.47% | 45,100 | 235億1692万 | -2.01% |
07/13 | 1,908 | 1,924 | 1,901 | 1,915 | +0.42% | 34,400 | 236億2796万 | -1.49% |
07/12 | 1,944 | 1,944 | 1,906 | 1,907 | -0.83% | 59,200 | 235億2926万 | -1.85% |
07/11 | 1,950 | 1,962 | 1,922 | 1,923 | -0.57% | 36,100 | 237億2667万 | -1.03% |
07/10 | 1,930 | 1,945 | 1,919 | 1,934 | -0.31% | 32,500 | 238億6239万 | -0.46% |
07/07 | 1,939 | 1,966 | 1,924 | 1,940 | -0.46% | 45,000 | 239億3642万 | -0.15% |
07/06 | 1,951 | 1,961 | 1,935 | 1,949 | -1.32% | 37,900 | 240億4747万 | +0.36% |
07/05 | 1,979 | 1,990 | 1,967 | 1,975 | -0.65% | 33,400 | 243億6827万 | +1.8% |
07/04 | 1,969 | 1,989 | 1,952 | 1,988 | +0.81% | 33,700 | 245億2866万 | +2.63% |
07/03 | 16:00 取締役の役職および委嘱事項に関するお知らせ |
07/03 | 16:00 連結子会社の商号変更に関するお知らせ |
07/03 | 1,975 | 1,992 | 1,966 | 1,972 | +0.36% | 51,000 | 243億3125万 | +1.96% |
06/30 | 1,954 | 1,965 | 1,935 | 1,965 | +0.31% | 51,100 | 242億4488万 | +1.76% |
06/29 | 1,956 | 1,971 | 1,946 | 1,959 | +0.67% | 63,400 | 241億7085万 | +1.56% |
06/28 | 1,922 | 1,947 | 1,918 | 1,946 | +0.83% | 83,600 | 240億1045万 | +0.93% |
06/27 | 1,966 | 1,966 | 1,907 | 1,930 | -2.48% | 119,700 | 238億1304万 | +0.16% |
06/26 | 1,958 | 1,994 | 1,941 | 1,979 | +1.07% | 98,600 | 244億1762万 | +2.7% |
06/23 | 2,000 | 2,015 | 1,941 | 1,958 | -1.71% | 118,600 | 241億5851万 | +1.66% |
06/22 | 1,971 | 1,998 | 1,964 | 1,992 | +1.58% | 65,700 | 245億7802万 | +3.48% |
06/21 | 1,973 | 1,990 | 1,953 | 1,961 | -0.66% | 83,800 | 241億9553万 | +2.03% |
06/20 | 1,941 | 1,974 | 1,925 | 1,974 | +1.54% | 80,500 | 243億5593万 | +2.76% |
06/19 | 1,935 | 1,944 | 1,916 | 1,944 | +0.47% | 49,100 | 239億8578万 | +1.25% |
06/16 | 1,912 | 1,939 | 1,905 | 1,935 | +2.38% | 81,600 | 238億7473万 | +0.83% |
06/15 | 1,913 | 1,916 | 1,890 | 1,890 | -1.36% | 71,600 | 233億1950万 | -1.61% |
06/14 | 1,920 | 1,933 | 1,913 | 1,916 | -0.21% | 48,800 | 236億4030万 | -0.16% |
06/13 | 1,946 | 1,950 | 1,919 | 1,920 | -0.83% | 51,500 | 236億8966万 | +0.21% |
06/12 | 1,914 | 1,946 | 1,910 | 1,936 | +2.22% | 96,300 | 238億8707万 | +1.1% |
06/09 | 1,906 | 1,917 | 1,892 | 1,894 | +0.85% | 62,900 | 233億6886万 | -0.89% |
06/08 | 1,916 | 1,919 | 1,873 | 1,878 | -1.88% | 93,600 | 231億7144万 | -1.57% |
06/07 | 1,944 | 1,952 | 1,912 | 1,914 | -0.83% | 77,700 | 236億1563万 | +0.53% |
06/06 | 1,910 | 1,932 | 1,897 | 1,930 | +0.52% | 56,000 | 238億1304万 | +1.58% |
06/05 | 1,933 | 1,934 | 1,905 | 1,920 | -0.31% | 57,100 | 236億8966万 | +1.32% |
06/02 | 1,890 | 1,926 | 1,888 | 1,926 | +2.01% | 58,300 | 237億6369万 | +1.9% |
06/01 | 1,927 | 1,927 | 1,886 | 1,888 | -1.2% | 58,100 | 232億9483万 | +0.11% |
05/31 | 1,908 | 1,933 | 1,896 | 1,911 | +0.21% | 63,000 | 235億7861万 | +1.49% |
05/30 | 1,905 | 1,920 | 1,870 | 1,907 | +0.21% | 83,200 | 235億2926万 | +1.44% |
05/29 | 15:30 2023年3月期(第26期)決算説明資料 |
05/29 | 15:30 (開示事項の経過)当社子会社の臨床用iPS細胞作製技術の住友ファーマによる米国企業への再実施権行使のお知らせ |
05/29 | 1,934 | 1,934 | 1,902 | 1,903 | -1.09% | 57,200 | 234億7990万 | +1.39% |
05/26 | 1,931 | 1,937 | 1,918 | 1,924 | -0.31% | 40,900 | 237億3901万 | +2.61% |
05/25 | 1,945 | 1,945 | 1,915 | 1,930 | +0.36% | 54,100 | 238億1304万 | +3.1% |
05/24 | 18:00 当社子会社によるSTEMCELL Technologies社とのiPS細胞作製技術に関するライセンス契約締結のお知らせ |
05/24 | 1,916 | 1,940 | 1,908 | 1,923 | -0.31% | 42,500 | 237億2667万 | +2.89% |
05/23 | 17:35 役員人事に関するお知らせ |
05/23 | 1,957 | 1,970 | 1,916 | 1,929 | -0.52% | 93,900 | 238億70万 | +3.38% |
05/22 | 15:30 新型コロナウイルスワクチンの規定接種完了者を対象としたIRO-203追加接種(経鼻)第1相臨床試験開始のお知らせ |
05/22 | 1,925 | 1,949 | 1,924 | 1,939 | 0% | 44,300 | 239億2408万 | +4.14% |
05/19 | 1,928 | 1,944 | 1,912 | 1,939 | +0.41% | 75,800 | 239億2408万 | +4.3% |
05/18 | 1,946 | 1,946 | 1,910 | 1,931 | +0.36% | 85,700 | 238億2538万 | +4.04% |
05/17 | 1,945 | 1,950 | 1,918 | 1,924 | -1.03% | 85,800 | 237億3901万 | +3.89% |
05/16 | 1,939 | 1,947 | 1,917 | 1,944 | +0.52% | 74,500 | 239億8578万 | +5.14% |
05/15 | 1,947 | 1,947 | 1,904 | 1,934 | -1.88% | 217,300 | 238億6239万 | +4.82% |
05/12 | 1,961 | 2,034 | 1,951 | 1,971 | +7.06% | 719,900 | 243億1891万 | +7.12% |
05/11 | 15:30 2023年3月期決算短信〔日本基準〕(連結) |
05/11 | 15:30 剰余金の配当に関するお知らせ |
05/11 | 1,857 | 1,863 | 1,832 | 1,841 | -0.59% | 79,900 | 227億1492万 | +0.27% |
05/10 | 1,885 | 1,885 | 1,845 | 1,852 | -1.75% | 73,700 | 228億5065万 | +0.82% |
05/09 | 1,900 | 1,911 | 1,865 | 1,885 | +2.06% | 173,600 | 232億5781万 | +2.5% |
05/08 | 15:30 当社子会社によるJanssen Biotech社とのiPS細胞作製技術を用いた製品開発および販売に関するライセンス契約締結のお知らせ |
05/08 | 1,806 | 1,849 | 1,801 | 1,847 | +2.21% | 82,300 | 227億8896万 | +0.44% |
05/02 | 1,790 | 1,811 | 1,784 | 1,807 | +0.89% | 64,800 | 222億9542万 | -1.74% |
05/01 | 1,804 | 1,815 | 1,783 | 1,791 | -0.72% | 78,400 | 220億9801万 | -2.61% |
04/28 | 1,793 | 1,820 | 1,790 | 1,804 | +0.5% | 57,900 | 222億5841万 | -1.96% |
04/27 | 1,791 | 1,799 | 1,785 | 1,795 | -0.33% | 33,500 | 221億4736万 | -2.39% |